Principles of Oxygen Therapy and Sleep Apnoea Flashcards
When would a Nasal Cannulae be used to deliver oxygen?
- delivering less flow rate
- delivers 24-40% O2
- mild hypoxaemia
- not critically ull
- flow rate 1-4L/min
What are advantages of a Nasal Cannulae
- able to speak
- able to eat
- less claustrophobic
What disadvantages are there to nasal cannulae?
- drying of nasal cavity
When would an uncontrolled mask (hudson mask) be used?
- deliver medium to high flw rate
- 5-10L/min
- 30-60% O2 delivered
- less drying
When would a rebreathe uncontrolled mask be used?
- high oxygen saturation 85-90%
- high flow rate 12L/min
- very unwell patients
- COPD
When would oxygen be given as a treatment?
- acutely hypoxaemic patients
- reduced oxygen saturations
- acutely unwell patients that show signs of further deterioration
What are is the target oxygen saturations?
- Young adult: 96%-98%
- Over 70yrs: 94-98%
- Those at risk of hypercapnic respiratory failure: 88-92%
What is the treatment for acute breathlessness with hypoxemia?
- Maximal oxygen treatment
- High flow uncontrolled mask (first-line treatment)
- Alter flow and delivery device when stable
Target SpO2 = 94-98%
Who is at risk of hypercapnia if given a high dose of oxygen?
- Chronic hypoxic lung disease: COPD, Bronchiectasis/ Cystic fibrosis
- Chest wall disease: Kyphoscoliosis, Thoracoplasty
- Neuromuscular disease
- Obesity-related hypoventilation
What is hypercapnia?
- CO2 retention
What is seen in chronically hypoxaemic patients with COPD who have acute exacerbation?
- They have increasingly worsening breathing
- the exacerbation may be a viral or bacterial infection or an episode of heart failure (inadequate perfusion)
What can untreated hypoxaemic patients develop?
- pulmonary hypertension
- right ventricular failure
- right ventricular hypertrophy
- secondary polycythaemia (raised Haemoglobin)
When would a patient have Long Term Oxygen Therapy (LTOT)?
- some COPD patients
- pO2 <7.3kPa
or - pO2 7.3<8kPA and, secondary polycythamia, nocturnal hypoxemia, peripheral oedema/ evidence of RV failure. evidence of pulmonary hypertension
- pO2 <7.3kPa
What are the benefits of Long term Oxygen Therapy (LTOT)?
- Improved long term survival
- Prevention of deterioration in pulmonary hypertension cases
- Reduction of polycythaemia (raised Hb)
- Improved sleep quality
- Increased renal blood flow
- Reduction in cardiac arrhythmias
- Improved quality of life
What is LTOT
Long term oxygen therapy